Please ensure Javascript is enabled for purposes of website accessibility
Novo Nordisk A/s Stock Quote

Novo Nordisk A/s (NYSE: NVO)

Price as of February 3, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Novo Nordisk A/s Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NVO +30.74% +171.03% +22.04% +37,635%
S&P -7.62% +49.76% +8.40% +3,099%

Novo Nordisk A/s Company Info

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

News & Analysis

The Fool has written over 200 articles on Novo Nordisk A/s.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 02/04/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.